When Mounjaro activates both receptors together, your appetite drops more sharply, your body becomes better at burning fat for energy, and the overall weight loss effect is stronger
In addition, it was shown that the factors of diabetes duration, sex percentage, study sample size, studies with significant results, and comparisons between GLP-1RAs and placebo could clarify the sources of the heterogeneity
Wegovy works similarly by targeting GLP-1 receptors, but its higher dosage makes it particularly effective for weight loss
Its ability to stabilize actin monomers contributes to cellular motility and differentiation
Consequently, long-acting GLP-1 RAs resistant to DPP-4 degradation, such as dulaglutide and semaglutide, have been developed for the treatment of T2D and obesity